132 related articles for article (PubMed ID: 19574484)
1. Incidence of second cancers after allogeneic hematopoietic stem cell transplantation using reduced-dose radiation.
Hsieh MM; Fitzhugh CD; Tisdale JF
Blood; 2009 Jul; 114(1):225; author reply 225-6. PubMed ID: 19574484
[No Abstract] [Full Text] [Related]
2. Malignancies after hematopoietic stem cell transplantation: many questions, some answers.
Deeg HJ; Socie G
Blood; 1998 Mar; 91(6):1833-44. PubMed ID: 9490664
[No Abstract] [Full Text] [Related]
3. Current role of allogeneic stem cell transplantation in follicular lymphoma.
Farina L; Corradini P
Haematologica; 2007 May; 92(5):580-2. PubMed ID: 17488679
[No Abstract] [Full Text] [Related]
4. Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies.
Ricardi U; Filippi AR; Biasin E; Ciammella P; Botticella A; Franco P; Corrias A; Vassallo E; Ragona R; Fagioli F
Strahlenther Onkol; 2009 Aug; 185 Suppl 2():17-20. PubMed ID: 19685029
[No Abstract] [Full Text] [Related]
5. Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood.
Keslova P; Formankova R; Riha P; Sramkova L; Snajderova M; Malinova B; Luks A; Sterba J; Stary J; Sedlacek P
Neoplasma; 2020 Sep; 67(5):1164-1169. PubMed ID: 32657609
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
Kal HB; van Kempen-Harteveld ML
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1525. PubMed ID: 18022583
[No Abstract] [Full Text] [Related]
7. Second malignancies after allogeneic stem cell transplantation with reduced-intensity conditioning: is the incidence reduced?
Shimoni A
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1669-70. PubMed ID: 25223487
[No Abstract] [Full Text] [Related]
8. Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.
Fassas AB; Tricot G
Cancer Treat Res; 2001; 108():169-84. PubMed ID: 11702599
[No Abstract] [Full Text] [Related]
9. Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation.
Sengeløv H; Petersen PM; Fog L; Schmidt M; Specht L
Bone Marrow Transplant; 2019 Aug; 54(8):1369-1371. PubMed ID: 30718801
[No Abstract] [Full Text] [Related]
10. The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation.
Delgado J; Cooper N; Thomson K; Duarte R; Jarmulowicz M; Cassoni A; Kottaridis P; Peggs K; Mackinnon S
Biol Blood Marrow Transplant; 2006 Jan; 12(1):75-83. PubMed ID: 16399571
[TBL] [Abstract][Full Text] [Related]
11. Osteochondroma after pediatric hematopoietic stem cell transplantation: report of eight cases.
Bordigoni P; Turello R; Clement L; Lascombes P; Leheup B; Galloy MA; Plenat F
Bone Marrow Transplant; 2002 Apr; 29(7):611-4. PubMed ID: 11979312
[TBL] [Abstract][Full Text] [Related]
12. Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation.
Ziegler AK; Abend M; Port M; Dammann E; Homeyer RS; Eder M; Ganser A; Schrem H; Koenecke C
Bone Marrow Transplant; 2019 Apr; 54(4):635-640. PubMed ID: 30337701
[No Abstract] [Full Text] [Related]
13. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.
Ho VT; Weller E; Lee SJ; Alyea EP; Antin JH; Soiffer RJ
Biol Blood Marrow Transplant; 2001; 7(4):223-9. PubMed ID: 11349809
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.
Harada K; Yanada M; Machida S; Kanamori H; Onizuka M; Ozawa Y; Kobayashi H; Sawa M; Katayama Y; Ohashi K; Kanda J; Ichinohe T; Atsuta Y; Yano S
Leuk Lymphoma; 2019 Jun; 60(6):1493-1502. PubMed ID: 30457400
[TBL] [Abstract][Full Text] [Related]
15. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.
Krishnan A; Bhatia S; Slovak ML; Arber DA; Niland JC; Nademanee A; Fung H; Bhatia R; Kashyap A; Molina A; O'Donnell MR; Parker PA; Sniecinski I; Snyder DS; Spielberger R; Stein A; Forman SJ
Blood; 2000 Mar; 95(5):1588-93. PubMed ID: 10688812
[TBL] [Abstract][Full Text] [Related]
16. A Single-Center Experience With Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia: A Modest Pitch for Non-Total Body Irradiation Conditioning Regimens.
Hamidieh AA; Eslami Shahre Babaki A; Rostami T; Kasaeian A; Koochakzadeh L; Sharifi Aliabadi L; Behfar M; Ghavamzadeh A
Exp Clin Transplant; 2019 Apr; 17(2):243-250. PubMed ID: 30295587
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
Berglund A; Enblad G; Carlson K; Glimelius B; Hagberg H
Eur J Haematol; 2000 Jul; 65(1):17-22. PubMed ID: 10914935
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Jeon YW; Yoon S; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):345-355.e7. PubMed ID: 31014757
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation.
Herr MM; Curtis RE; Tucker MA; Tecca HR; Engels EA; Cahoon EK; Battiwalla M; Buchbinder D; Flowers ME; Brazauskas R; Shaw BE; Morton LM
J Am Acad Dermatol; 2020 Sep; 83(3):762-772. PubMed ID: 31654664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
